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Abstract: The aim of this article is to present an overview of salient issues of  
exposure, characterisation and hazard assessment of nanomaterials as they emerged from 
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the consensus-building of experts undertaken within the four year European Commission 
coordination project NanoImpactNet. The approach adopted is to consolidate and condense 
the findings and problem-identification in such a way as to identify knowledge-gaps and 
generate a set of interim recommendations of use to industry, regulators, research bodies 
and funders. The categories of recommendation arising from the consensual view address: 
significant gaps in vital factual knowledge of exposure, characterisation and hazards;  
the development, dissemination and standardisation of appropriate laboratory protocols; 
address a wide range of technical issues in establishing an adequate risk assessment 
platform; the more efficient and coordinated gathering of basic data; greater  
inter-organisational cooperation; regulatory harmonization; the wider use of the life-cycle 
approaches; and the wider involvement of all stakeholders in the discussion and  
solution-finding efforts for nanosafety. 
Keywords: nanomaterial characterisation; release; exposure; hazard; nanotoxicology; 
nanosafety; occupational health; consensus building; life cycle approach; monitoring; protocols 
 
1. Introduction 
The question of the safety of nanomaterials (NMs) is one of increasing urgency as these  
materials enter into a wider and wider range of manufacturing processes, industrial and consumer  
goods and waste management processes (See the nanoproducts inventories [1]). A recent consensual 
report of experts in the field of nanosafety identified a general lack of coherent, consistent and  
well-founded data, the need for realistic exposure scenarios, better established dose–response 
relationships, improved extrapolation from in vitro to in vivo, and the identification of the most 
relevant assessment parameters [2]. In particular, there is a need: (1) to understand the dynamics of 
biological-nanomaterial interfaces. This includes, in the determination of NM fate and behaviour, the 
role and importance of the corona of biomolecules that tends to form around NMs in contact with 
environmental or biological fluids; (2) to embark on long-term and repeated low dose studies;  
and (3) to gather information about NM stability and reactivity and transformation throughout the NM 
lifecycle [2]. On the regulatory front the existing test guidelines need to be adapted for manufactured 
NMs, and on the nanosafety research front more advanced statistical and computational methods are 
required [2]. 
Over its four years of activity, NanoImpactNet hosted workshops on a range of key topics and 
developed consensus reports on a range of topics regarding the impact of NMs on living systems, as 
summarised in Table 1. At the close of the project, these findings were consolidated into a consensus 
report and a set of recommendations tailored for the different stakeholder groups of relevance for 
nanosafety, including industry, funding agencies and the research community [3], which is summarised 
in this article. This view is an attempt to bring together the diverse findings, conclusions and opinions 
of a large number and variety of specialists working in many different disciplines related directly or 
indirectly to the environmental, health and safety aspects of NMs. Included are chemists, biologists, 
material scientists, physicists, toxicologists, occupational health experts, environment and ecology 
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specialists as well as those working in regulation, insurance, technology communication and 
standardisation. NanoImpactNet comprised 24 European research groups and as a result of its combined 
activities an engaged community with over 1,000 members was created and actively participated in 
nanosafety-related events. Although disagreement was to be expected within this emergent community, 
the authors suggest that an overall narrative appears, as outlined in this article [3]. 
Table 1. Summary of the NanoImpactNet Workshops and resulting reports. 
Workpackage Workshop Title Report Title 
Human Hazard & 
Exposure (WP1) 
Standardization of materials and protocols 
Minimal analytical characterisation of engineered 
nanomaterials need for hazard assessment in 
biological matrices [4]; 
First approaches to standard protocols and reference 
materials for the assessment of potential hazards 
associated with nanomaterials [5]; 
Best practice documents for handling, testing safety  
Methods to describe and measure  
exposure routes/QA 
Nanoparticle metrics in the air, exposure scenarios 
and exposure routes [6] 
Protocols for assessment of biological 
hazards Biological responses 
Protocols for assessment of biological hazards of 
engineered nanomaterials [7] 
Development of strategies to assess 
occupational health effects 
Strategies for assessing occupational health effects of 
engineered nanomaterials [8,9] 
Environmental 
Hazard & 
exposure (WP2) 
Strategies to standardize nanomaterials  
for environmental and ecotoxicological 
research 
Nanomaterials for environmental studies: 
Classification, reference material issues, and 
strategies for physico-chemical characterisation [10];
Recommendations of protocols and approaches to 
study environmental impacts of nanomaterials [11] 
Development of standardized protocols  
to determine fate and behaviour  
in the environment 
Environmental fate and behaviour of  
nanoparticles—beyond listing of limitations [12] 
Optimization of current standard protocols 
to allow assessment of nanomaterial 
hazard in a range of organisms 
Optimization of current standard protocols to allow 
assessment of nanomaterial hazard in a range of 
organisms [13] 
Life Cycle 
Assessment 
(WP3) 
Life cycle assessment of  
nanomaterial-containing products 
The importance of life cycle concepts for the 
development of safe nanoproducts [14] 
Risk assessment of nanomaterials Consensus Report - Risk Assessment of 
Nanomaterials: In vitro–in vivo extrapolation [15] 
Impact assessment of nanomaterials Final report with recommendations for Impact 
Assessment of Nanomaterials [16] 
The aim here is to present this narrative on the most significant issues of exposure and hazard 
assessment of NMs with a view to generating interim recommendations of use to industry, regulators, 
research bodies and funders.  
The consensual overview is divided into considerations of exposure, hazard, characterisation and 
the recommendations for the different stakeholder groups.  
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2. Exposure 
The control of the potential exposure to any hazardous material in the occupational setting is 
crucial. In the traditional risk framework, risk management decisions concerning occupational safety 
and health rely on site-specific risk assessment and information about the effectiveness of available 
measures to mitigate exposure [17].  
2.1. Methods and NM Aggregation 
The current method of assessing worker exposure to airborne particles in the workplace involves 
measurement of the mass concentration of health-related fractions of particles in the worker’s 
breathing zone. The main exception to this methodology are particle-number-based metrics for 
exposure for fibres and for micro-organisms [18,19]. However, nanoparticles carry extremely small 
masses and therefore generally contribute negligibly to the integral mass concentration of the inhalable 
or respirable dust fraction [20]. Besides, such a measure cannot distinguish exposure to engineered 
NMs from background levels of similar sized anthropogenic or ambient particles. Other metrics such 
as particle number concentration or surface area may be better descriptors for the biological effects of 
nanoparticles. The issue of exposure metrics has extensively been addressed by Maynard and  
Aitken [21], and they conclude that effective approaches for measuring exposure to a wide range of 
manufactured NMs/nano-objects will require methods for measuring aerosol number, surface area and 
mass concentration. 
The most widespread method for determining airborne sub-micron particle number concentrations 
as a function of particle size, i.e., particle number size distribution, is based on electrical mobility 
analysis of the particles [22]. This technique usually comprises three main components: (1) a particle 
charger to charge particles predictably depending on their size; (2) a mobility analyser which classifies 
the particles of one polarity according to their electrical mobility; and (3) a particle counter that 
determines the number concentration of the mobility-classified particles. These three components are 
usually employed in what has become the workhorse for occupational exposure measurements: the 
Scanning Mobility Particle Sizer (SMPS) or the somewhat more sensitive Fast Mobility Particle Sizer 
(FMPS). The International Standards Organisation (ISO) standard ISO/TR 27628 further describes the 
available methods to measure the above mentioned metrics of nano-objects [23].  
However, for SMPS, no standard method has been agreed upon to produce reference particle 
number concentration [22]. Furthermore these instruments are bulky, expensive and complicated to 
use, and are therefore usually only operated by research groups and not by practitioners in SMEs for 
example. Fortunately, smaller and even portable devices are now appearing (e.g., from the EU FP7 
NanoDevice project [24]). The SMPS also gives no information on the chemical identity of the 
counted particles. The latter is also true for the available small portable devices like the Condensation 
Particle Counter (CPC), diffusion size classifiers [25] or surface area monitors. Though they give no 
information of the size distribution they can be used for assessing sources of NMs or the effectiveness 
of control measures. The state of the art method to obtain information about size and shape as well as 
chemical identity and state of agglomeration is the subsequent analysis by electron microscopy of a 
taken sample. But no standards for sampling or analyse exist yet [20].  
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One major finding of most current studies is that during the production and handling of 
nanoparticles the workplace concentration of particles below 100 nm is close to the background 
concentration in most manufacturing companies. This background aerosol consists of ubiquitous 
ultrafine particles from sources in or outside e.g., particles emitted from diesel engines by trucks or 
forklifts, welding fumes or even vacuum cleaners with electric motors close to the process. Aggregates 
or agglomerates above 100 nm in size are quite often detected at the workplace and correlate with 
operations, further complicating detection and discrimination of NMs by existing measurement  
devices [26]. This is in line with theoretical calculations indicating that most of the particles emitted 
from processes are agglomerated when reaching the exposed person [27].  
Recommendation 1: Research is needed into the safety implications of aggregation and 
agglomeration, especially a possible ‘Trojan Horse effect’. Emitted nanoscale entities may be loosely 
attached to bigger agglomerates and therefore may not be detected by the measurement devices in the 
size range below 100 nm. These aggregates and agglomerates can be still respirable. On inhalation 
they may even reach the alveoli of the lungs. They may be released in their primary size range after 
contact with lung surfactant. Of course, we should not only be concerned about the primary size. 
Research is needed into the aggregation/disaggregation mechanisms involved [20].  
2.2. Release of NMs (from the Product) into the Environment  
Some early studies evaluated the release of NMs into the wider environment from some selected 
nanomaterial-containing products during the consumption phase [28,29]. One study used life-cycle 
based modelling and embraced the whole life-cycle of products that contain certain NMs [30]. This 
study provided the first comprehensive assessment of the potential concentrations and the associated 
environmental risks of nano-TiO2, nano-Ag and carbon nanotubes (CNTs). These studies estimated 
concentration levels of selected NMs in different systems (aquatic, terrestrial, waste-water systems) 
based on the available knowledge of the total usage of products containing NMs. 
While the release of NMs is obviously a precondition of downstream exposure, little has been done 
so far to examine such release in a rigorous and systematic manner. General processes and areas of 
possible release of nanoscale entities and NMs are: the production process; the handling, packaging, 
use and misuse of such materials; the ageing processes of NMs; and end-of-life activities such as 
recycling and disposal [14]. 
Possible release during production may occur through leaks to water and air in closed systems or 
open production processes. These have been studied in several European and national studies such as 
NANOSH, CarboSafe and NanoGEM [31]. The areas of “handling and use” and “ageing” are vast and 
complex. The former includes the handling of powders, diffuse emission from production plants, 
mechanical treatment of NMs such as sanding and drilling, abrasion during use, spraying of  
‘nano’-sprays. The latter covers all processes taking place in the environment such as selective wear 
and tear, degradation, wash-out, and the increased brittleness of some materials. 
End-of-life activities include: (1) re-use or recycling, such as disassembling, and mechanical or 
thermal processes like crushing, melting and torch cutting; (2) waste treatment, such as incineration; 
and (3) disposal, such as landfill. The release of nanoscale entities can never be excluded as a 
possibility, especially during high energy processes.  
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Recommendation 2: There is a general lack of knowledge on the release of NMs. More research 
and development activities need to be aimed at understanding the release of NMs from processes  
and products during use. This applies both to standard non-nanotechnology processes and to new 
nanotechnology-related processes. Specifically we need: (a) detailed studies of processes including the 
nanoscale; (b) standardised testing for certain possibly relevant mechanisms and routes of release;  
(c) the derivation of quantitative information on the possible release rates; and (d) characterisation of 
the physical, chemical and bio-interface properties of NMs that are dependent on specific release 
conditions (e.g., abrasion) that is useful for safety measures.  
Recommendation 3: Concerning release, for safety purposes we need data on the leach rate and/or 
decay rate of nanoscale entities in realistic landfill conditions. We already know that free NMs can 
penetrate clay (typically used as a liner in landfill) and move into ground water, so the expectation is 
that there will be some long-term slow release at the end of a product’s life. Of course, at this early 
stage, if product manufacturers can design for re-use then the amount going to landfill may be reduced.  
2.3. Workplace Exposure Measurements 
A limitation on nanosafety development is the lack of information about the health of already 
exposed and thus potentially affected populations. There was (and still is) no European system to 
register occupational health related to nanomaterial exposure. Consequently, occupational health 
reporting strategies need further exploration and harmonization [9,8]. The workplace is generally  
the best characterised exposure scenario due to the expected highest exposure probability and 
concentrations for humans. Still most of the studies conducted to date have been on general  
exposure or release. That is, no specific personal exposure measurements for nanoparticles at various 
workplaces, leading to a robust exposure assessment via inhalation or oral uptake, have been 
conducted so far [9,8].  
Dermal exposure to NMs has not been studied with the exception of Van Duuren-Stuurman  
et al. [32] using a shortened version of the observational dermal exposure assessment (DREAM) to 
estimate the likelihood of exposure. However, the relevance of uptake via the intact skin has been 
demonstrated [33]. With the exception of the intended use of NMs in food, possible oral uptake 
following inhalation exposure has not been studied yet. 
All nano-exposure studies conducted so far are related to short-term exposures. No procedure  
of exposure monitoring or long term exposure assessment has been conducted to the knowledge of the 
authors. The current workplace investigations focus on areas where NMs are initially produced. 
Knowledge on use and processes with NMs in the secondary or later stages cannot currently be 
assessed due to lack of knowledge on their use. Labelling, which is also needed to identify possible 
exposure via consumer goods, is one way to address this safety research topic [34]. 
Comparative assessments of different tasks and processes in the workplace should be based on an 
extensive data set generated in as harmonised a way as [35]. The data should come along with 
auxiliary contextual information that is required to interpret the measurement results for risk 
assessment and mediation purposes. The exposure scenarios are also needed to derive information on 
uptake for combined assessments of hazard and exposure potential. 
Materials 2013, 6 1096 
 
 
Recommendation 4: We recommend the early development and testing of personal devices 
delivering reliable results to reduce NMs exposure in the workplace. Focus should be set to personal 
real-time instruments that simulate uptake, e.g., deposition in the different areas of the respiratory tract.  
2.4. Safe Handling of Nanomaterials  
Accountability for workplace safety is the preparedness to provide to the relevant stakeholders an 
adequate account of preventive procedures followed. This will depend on clear documentation of all 
steps involved during handling of NMs including available data on the specific materials involved, the 
measures taken to provide safe handling; surveys of measures taken for safe handling on a regular 
basis; and the introduction of a health surveillance system related to nanomaterial production and use. 
The principle of protecting workers by handling procedures that prevent and minimise exposure 
applies also to NMs, but special account needs to be taken of specific characteristics such as their 
strong tendency to reduce their surface energy by agglomerating or binding to available molecules. 
Safe systems of work such as those exemplified to the Control of Substances Hazardous to Health 
(COSHH [36]) seem appropriate for NMs. The evidence so far is that routine protective measures such 
as rubber gloves, the use of dust masks suitable for ultrafine materials, and safety glasses also work for 
NMs when modest volumes are used (such as in the research laboratory). Safety managers should not 
be unduly concerned that strategies or normal procedures will not work. However, the information in 
the public domain used for these risk assessments needs updating for NMs. For example, the 
information on material safety data sheets (MSDS) should be specific to the material, and not generic 
information for an existing chemical form of the same substance. For example, an MSDS specific for 
“carbon nanotubes”, not just for ‘carbon’, is required to adequately address the potential risks of  
these NMs. 
Recommendation 5: The handling of NMs in powdered form should be kept to a minimum, 
especially for high aspect ratio NMs (e.g., nanotubes, nanorods and nanowires) and must be performed 
under appropriate ventilation conditions (ideally in a closed system, but at least a fume hood) and 
wearing appropriately refined personal protection equipment (safety glasses, mask, gloves and lab coat 
or protective suit). Based on current best-practice, all solid or powdered NMs need to be labelled for 
safe work procedures [37,38]. 
Recommendation 6: For commercially available NMs, where a nano-specific MSDS exists (e.g., 
created following the Swiss recommendations [39], this should be stored in a file in the laboratory or 
company for each nanomaterial. It is important to note however, that most nano-specific MSDS are 
currently incomplete and often state that no information is available regarding the hazards or  
exposure consequences. For laboratory synthesised samples especially there may be very little safety 
information available and limited information regarding the storage and handling conditions. An 
MSDS for the nearest available commercial nanomaterial or the base material should be obtained and 
stored in the laboratory, with a note attached saying that this is a material similar to that being utilised 
and similar conditions would apply. The same applies if the MSDS pertains to a non-nanoscale form, 
to the effect that there may be additional or different risks associated with the nanoscale form of the 
material and to apply caution when handling.  
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Recommendation 7: Steps should be initiated where and when appropriate for an ongoing review 
of all workplace particulate protection equipment in the light of developing nano-hazard and safety 
findings, and with a view to the standardisation of relevant to nanoscale hazards.  
Recommendation 8: Many workers undergo annual health surveillance as part of risk management 
strategies. A mechanism needs to be in place so that the doctors conducting these assessments are kept 
up to date with adverse effects that are specific to possible NM exposure. For example, the focus on 
lung function tests for dusts might distract attention away from other risks such as immunological 
health, or cancer risks. At the earliest possible opportunity large-scale epidemiology studies and 
sample banks should be established as a resource for the future for re-analysis when specific  
nano-exposure and nano-hazard biomarkers emerge. 
2.5. Exposure via Consumer Products 
The public use of a wide range of nanotechnology-based consumer products will result in other 
exposure scenarios, involving for example the use, misuse and disposal of items of personal care, 
domestic cleaning, personal clothing, nano-coated products, food packaging and polymer containers 
such as bottles, pharmaceuticals and nano-electronic goods. So far, no systematic real-life  
consumer-related test scenarios of release of, and exposure to, NMs exist. Current knowledge is 
limited to selected tests conducted for a few spray and cream formulations and the like. We even lack 
adequate information on nanomaterial content in consumer products despite their large-scale and 
growing use. More detailed information on their use and application is needed to permit a better 
evaluation of possible exposure pathways. One of the main obstacles in studying consumer exposure is 
the reliable measurement of NMs in the different matrices of consumer goods. 
During consumer usage, NMs are of course subjected to mechanical, thermal and other 
environmental stress conditions. Studies based on the characterisation of airborne particle release due 
to individual processes can currently be roughly classified in terms of NMs used for coatings and NMs 
used for composites. Coatings could be understood as a thin layer of composite material, as the 
engineered nanoparticles are intentionally embedded in a matrix material such as a polymer. However, 
for exposure studies composites and coatings cannot simply be compared and have to be analysed in 
different ways. Current measurement approaches may be inappropriate for this purpose. For example, 
the relatively long duration of the current aerosol measurement restricts the intensity of abrasion. This 
means that with higher abrasion intensity the coating would be worn off before the measurement 
finishes. Therefore only a limited and possibly futile simulation of exposure is possible.  
Recommendation 9: Effective strategies to overcome the above-mentioned limitations have to be 
developed. These may be based on testing of different release processes and realistic exposure 
scenarios and routes for different consumer applications (e.g., inkjet printers, PET bottles containing 
nano-clays, nano-silver impregnated garments) to allow the use of specific nanoscale measurement 
techniques and assessments. To assess the real impact of nanomaterial on the environment and human 
health, it is necessary to characterize the NMs and released particles, with feasible and refined 
techniques, once released into the sphere of human consumption. 
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2.6. Dosimetry 
“Dose” in nanoparticle toxicology may be a more difficult concept to grasp than dose regarding, for 
example, highly soluble substances, as the dose does not always increase linearly with mass due to 
inherent tendency for NMs to agglomerate as a consequence of their high surface energy. Of course, 
the issue is also about which dose metric (metrology) do we need to apply in concentration-dose-response 
functions [5].  
Dose–response relationships need to be established for different dose metrics: mass, surface area, 
redox activity, etc. Then, we need research clarity on whether we are speaking only of the biologically 
available dose, and of what kind of NM. Availability is, for example, affected by aggregation and 
disaggregation, agglomeration and de-agglomeration. Considerations involve in vitro assessment, 
validity and round robin testing, dosimetry and the relationship to in vivo exposure and dosimetry. This 
should cover exposure dose, medium dose, delivered dose, intracellular dose, subcellular dose, as well 
as organism dose, tissue dose, etc. (p85, 89 et passim) [2]. 
Concerning dose and inhalation, there are currently very few measurement techniques that simulate 
aspiration efficiency and the deposition in the trachea-bronchial and alveolar regions, which results in 
a mismatch between the concentration measured, the concentration inhaled, and the estimate of the 
deposited dose. To obtain health-related exposure information, modeling techniques have to be applied 
to the data. This lack of health-related exposure data, among other factors, makes the establishment  
of occupational exposure limits challenging. Clearly a number of specific recommendations for 
researchers and funders on the study of NMs and dose are contained in the above considerations. 
Recommendation 10: Researchers need to be placed in a position to confirm the particular dose 
they are working with, in realistic exposure conditions. This includes detailed characterization of  
NM dispersions in situ under the assay conditions. Researchers need to be able to measure with 
determinable accuracy the internal dose in cells, as opposed to just reporting the mass of particles 
added to the media. The dosimetry must take account of issues such as NMs dispersion in the  
exposure media (which affects the available dose of NMs) and the potential for labels to leak out of  
labeled-NMs under biological conditions, confounding the interpretation of the uptake studies data.  
3. Characterisation 
The role and importance of characterising NMs, not just in their pristine as-synthesised state but 
also as they exist in situ in complex biological matrices, such as cell culture media for in vitro studies, 
became more fully appreciated in the course of the project. Unfortunately this aspect is still missing 
from many published articles. This is in part due to the fact that consensus has not yet been reached on 
the minimal characterisation requirements for NMs (as powders, in simple dispersions and in situ as 
presented to living systems) and also because research that is currently published was conceived at a 
time before the need for good characterisation in situ was widely understood [4]. It would seem that 
which characterisation parameters are relevant and important depends on the specific NM and its 
context; therefore it may be a conceptual error to think there is a once-for-all basic and multi-purpose 
characterisation set for each “kind” of nanoparticle [40]. 
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3.1. Characterising Released Nanomaterials 
The major obstacle in studying NMs release, transformation and exposure is the characterisation of 
the particles themselves especially in complex matrices like the ecological environment or in a living 
organism. Even discrimination between particles by general type, such as engineered (e.g., CNTs) or 
natural (e.g., volcanic) or incidental (e.g., traffic pollutants), is difficult but of great importance when 
assessing exposure and for analyses that interface with health studies. In real-life scenarios the 
researcher may be presented with a “soup” of diverse nanoparticles to analyse and understand. This 
problem increases as the specific NMs become ever more removed from the actual source (both in 
time and space).  
Certainly, in a defined workplace environment specific NMs may be expected and the release and 
exposure can be targeted using specific search criteria and protocols, and hence it is often possible to 
limit resources to stipulate parameters exactly fitting the purpose. Some strategies and techniques have 
been developed and tested in workplaces (reviewed in Kuhlbusch et al. [41] However, severe 
limitations exist even for research purposes and the existing techniques cannot always be employed  
in routine workplace measurements. In the wider environment it becomes even more difficult or 
impossible to develop a reliable and feasible method as released NMs may undergo ageing and  
diverse transformations.  
The effect of such transformations—whether air, water, soil or biological media or systems—should 
ideally be taken into account in exposure modelling, where relevant. Examples of such changes 
include loss of coatings, change in coating composition, development of a “corona” (a fuzzy coating) 
which depends on the particle surface properties and the nature of the biomolecules and ions available 
in the surrounding milieu, and dissolution in liquid media. These changes are fast and dynamic  
and current technologies are not sufficiently well-developed to provide rapid assessments in a  
coherent manner.  
The main monitoring techniques currently employed do not necessarily give the kind of in situ 
characterisation needed. They are either microscopic methods for partial information on particle 
morphology, state of aggregation and chemical composition, or methods discriminating particles by 
size in relevant media (water, air, etc.). The latter sometimes allow subsequent separate analysis for 
chemical composition. Examples are an Aerosol Mass Spectrometer [42] or the Field Flow Fractionation 
technique coupled with mass spectrometry for liquids. Both methods provide information on  
particle-size dependent chemistry. 
Recommendation 11: Given the complexity, in the short term possible key release processes 
should be identified for particular products containing specific and characterisable NMs along the  
life-cycle. This would involve the identification of possible exposure routes and uptake paths of 
engineered NMs during the life-cycle, fate and behaviour of such materials in the environment, with 
exposure concentrations, and enabling a wider risk assessment. We need predictive models on how a 
nanomaterial will interact with and be transformed by its surroundings through time, and how these 
changes may influence subsequent transport, accumulation and reactivity. Such data generation would 
be complex and advanced computational techniques may be necessary to handle them for meaningful 
NM risk management. 
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3.2. Sample Preparation 
Many NMs are supplied as powders and need proper dispersion in vehicle media to allow the 
assessment of their human and environmental hazards [43]. The characterization of NMs in stock 
dispersions in ultrapure water or a physiological buffer is well-established and researchers generally 
agree on how to do this and what to measure. But, this agreement is harder to achieve for complex 
media (natural water, soil, cell culture media with serum proteins, and blood samples) because the 
NMs behave differently in each milieu, such as agglomeration or formation of a protein corona 
changing their surface reactivity and size. The addition of serum, albumin of detergents to allow a 
better and more stable dispersion could also modify the biological responses induced [44]. One 
solution to such sample preparation problems is to have a decision-tree about characterization based on 
what is possible in each type of media, and relevant for the exposure route and hazard end-point  
being assessed.  
A good dispersion without modification of NM characteristics, especially surface reactivity due to 
coating with proteins or other biomolecules, is necessary to mimic accurately real life exposures. This 
preparation of NMs should take into account the exposure routes and target organs to be studied. Thus 
during inhalation the nanoparticles will come into contact with lung lining fluid mainly composed of 
lipids, whereas ingested nanoparticles will encounter the acidic gastrointestinal fluids. Standardized 
dispersion protocols are established or under development to harmonize preparation methods (OECD 
guidelines) but their impacts on biological responses still need further investigation. 
Despite considerable progress, there is continuing uncertainty around specific issues such as the 
role of the synthesis route on the surface composition of nominally identical NMs. For example, silica 
nanoparticles can be prepared by at least five different routes, utilising different catalysts, etc., with the 
consequent emergence of subtle differences in the surface composition. Currently, researchers (and 
industry) do not distinguish between these as potentially different NMs, with potentially different 
uptake and impacts, and as such the published data are not always reliable and comparable.[45,46] 
A key communication issue is that authors are not reporting characterisation during the exposures, 
either because of logistical hurdles or because the technology is simply not reliable in the media and 
not with a low enough detection limit. 
Recommendation 12: We recommend that a pragmatic way forward is for manufacturers to 
cooperate in characterizing the relevant properties of the NMs at production (see Stone et al., 2010 for 
further details [10]), and to then further explore a very limited set of parameters before use (or 
exposure), e.g., size and size distribution, zeta potential and adsorbed species in order to take into 
account the effects of storage and sterilization and how different environments/conditions affect the 
physicochemical characteristics of NMs [4]. 
Recommendation 13: Industry, regulators and standards organizations should cooperate in 
generating a nomenclature system for NMs that accounts for synthesis route and potentially for surface 
description including initiator/catalyst residues and potential surface impurities or defects. If this 
proves to be too challenging, perhaps because there are too many variables, the solution may be to 
stick with the current chemical nomenclature and additionally indicate particle size and shape [10], 
adding to the chemical product labelling a code number for the synthesis method. Like other chemicals 
they also need to list major impurities that relate to the synthesis.  
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Recommendation 14: It is good practice for any assay to be cross-checked for interference, and  
the authors also emphasize that NM samples could interfere with the test assays themselves. We 
recommend the establishment of appropriate controls for such possible interference [7]. 
Recommendation 15: To develop robust procedures for routine testing of NMs with a high degree 
of credibility we make two recommendations: (1) cell lines which are readily available and traceable 
(i.e., same source and commercially available) should be used rather than specifically isolated/modified 
cell lines; and (2) cell line characterization, and reporting of degree of confluence/passage number/cell 
cycle duration etc., should be reported and included in any data for publication [5].  
Recommendation 16: Nanosafety and related researchers should be required by editors to include 
information about characterization and sample preparation in their papers. Some journals now have 
this requirement. 
If implemented, the above recommendations would facilitate the identification of differences in the 
base NMs that could be correlated with differences in their dispersion characteristics in the exposure 
medium and thus differences in their biological uptake and consequently differences in the observed 
dose-response characteristics in biological domains.  
3.3. Reference Materials and Batch Variability 
The development of characterisation methodologies and protocols, and hazard assessment assays 
and protocols requires an adequate body of reference NMs, which are available for comparison for a 
specific trait of the material (usually only one parameter such as chemical concentration for traditional 
chemicals). A certified standard is a sample that is certified for one parameter within a prescribed 
precision or accuracy. The EC’s Joint Research Centre (JRC) Institute of Reference Materials and 
Measurements has developed a certified reference NM (silica) and the Institute of Consumer Health 
and Protections has assembled an archive of test nanomaterials, on which there is some agreement on 
some characterization measurements. However, in all cases to date, the characterization is in water or 
simple buffer rather that in the relevant biological or environmental media. The U.S. Department  
of Commerce’s National Institute of Standards and Technology (NIST) is also trying to produce 
reference materials.  
It is difficult to see how the research community will make significant progress and reach consensus 
regarding the health and environmental impacts of NMs until NMs can be made reproducible from 
batch to batch, and/or we have a good understanding of the acceptable variability in specific NMs 
characteristics (e.g., size, size distribution, surface charge, surface impurities, surface chemistry, etc.). 
This is information that is absolutely necessary before cells or living organisms experience the NMs 
differently, in terms of uptake, localization, degradation/ bioaccumulation and impact.  
Of course the issue of batch-to-batch variability has a different relevance for different users. For 
example, academic researchers at least need to know exactly what is in the batch; industrial producers 
cannot scale up commercial activity until batch problems are resolved; and regulatory testers need a 
steady supply of the same thing for routine testing. Clearly, adequate regulation of NMs for application 
will require a high degree of reproducibility between batches, so there is a driver to resolve this issue. 
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Recommendation 17: More effort and urgency should be attached to the cooperative development 
of reference materials, useful both to nanomaterial developers and to those examining health, safety 
and environmental aspects [5]. 
Recommendation 18: More cooperative effort on minimizing batch variability is needed. Researchers 
should report the batch number and state the measured impurities, which are usually related to the 
synthesis method. 
3.4. Laboratory Protocols  
Much has been learned to date, but the variability of nanosafety related protocols (exposure, release, 
dosimetry, characterisation, hazard, etc.) renders the available information difficult to compare  
and interpret [47].  
The authors have been party to an online-space for sharing research protocols with other members 
within the project. The aim was to enable laboratories throughout the world to easily compare their 
methods and subsequently develop common protocols and strategies for the safety testing of NMs. 
While those in the field were motivated to discuss the harmonisation of nanoscience protocols, 
considerable effort and time are required for such harmonisation. It was not always evident who is the 
right or available individual, organisation or unit to perform this task.  
It also became clear in the project that protocols often need to be adapted to deal specifically with 
nanoscale materials and also that protocols suitable for one type of NM may not be applicable to other 
types [7]. 
Recommendations 19: Funding agencies should request specific protocol proposals from those 
applying for funding and could also require the definitive description of protocols in the final reports 
of funded projects. Research proposals should explain why a particular protocol was chosen over 
another. The development of nanosafety science would be supported if peer-review journals require 
authors to be absolutely specific in their description of protocols within the materials and methods 
section, not accepting a simple reference to previously published protocols that were “slightly adapted”.  
Recommendation 20: Careful characterization of all exposures, and understanding of biokinetics 
and mechanisms/mode of actions, should be encouraged for proposals for academic research  
into nanosafety. This is because without the exposure characterization, and without understanding 
biodistribution and persistence and mechanisms of action, hazard data cannot be interpreted for risk 
assessment purposes. Standard protocols for dispersion of nanoparticles should be agreed and 
differentiation between intrinsic NM responses and realistic exposure scenarios (in which NMs are 
more likely to be present as agglomerates) should be made.  
Recommendation 21: For many protocols, we recommend that tracking and visualisation techniques, 
in vitro and in vivo, be invented, improved and fine-tuned to allow NM identification, quantification 
and characterisation in situ [7].  
Recommendation 22: Overall, existing protocols are prone to artefacts and these should be well 
documented and publicized, so that all research publications include the control tests used to verify the 
applicability of the chosen assay to the particular NM being studied. Much can potentially be learned 
from the pharmaceutical and cosmetics industries, as well as from the current understanding of the 
biological hazards of ultrafine particles (transport pollution, etc.) [7]. 
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4. Hazard 
A great deal of groundwork was, and still is, necessary to make adequate human hazard assessment 
possible [4,13]. 
4.1. The Role of Hazard Assessment 
A hazard is a potential source of harm or adverse health effect on a person or persons. From an 
environmental and ecosystem point of view one would include a range of significant organisms since 
persons may be indirectly harmed by harm to such organisms, e.g., through the food chain, such as 
bacteria, phytoplankton, fish and earthworms. Human related hazard assessment relies on in vivo 
(animal) as well as in vitro experiments, because human data (either from human bio-monitoring or 
from accident studies) will most likely not be available. Both in vitro as well as in vivo studies are 
prone to give false positive/negative results as an in vitro system cannot cover all aspects of ADMET 
(adsorption, biodistribution, metabolism, excretion and toxicity) of NMs even though cells of human 
origin are often used.  
Neither in vitro nor in vivo systems can follow the same internal life cycle of NMs in tissue or cell 
environment (different proteins and metabolisms) as could be expected in human. Thus even more 
with engineered NMs than with conventional chemicals relevant hazard assessment has to be 
established for the purposes of a specific risk management activity, since risk (particularly in relation 
to occupational and consumer safety and health) is the likelihood that a person may be harmed or 
suffer adverse health effects if exposed to a hazard. Additionally, sensitive group such as children or 
people with certain diseases such with asthma, cardiovascular diseases or individuals with higher 
genetically predisposed susceptibility to NMs should be also taken into consideration.  
Hazard plus exposure puts us in the arena of risk and risk management. Nanosafety is concerned 
with the identification of new hazards (with occupational, health and environmental implications) 
arising from the specific character of manufactured (or “engineered”) nanoscale entities. The central 
question of the emerging discipline of nanosafety is therefore: What are the potential sources of harm 
or adverse health effects on a person or persons—and more broadly on organisms ecologically 
intertwined with the health of humans—that are specific to manufactured nanoscale entities and the 
materials in which they may be “embedded”? 
Although hazard assessment is logically prior to risk management, in creating a science and 
technology of nanosafety the researchers have to integrate across characterisation, hazard, release, 
exposure and risk management (which will always entail “risk perception”) [15]. Attempts must be 
made to bridge the traditional gap between exposure studies and hazard assessment studies (‘impact 
studies’), by designing an experimental strategy that would cover all these aspects. Ideally such a 
bridge would identify strategies for the simplification and harmonisation of experimental design whilst 
still capturing the major transformations undergone by NMs across their life cycle. In an integrated 
approach experiments would mimic more realistically the fate of NMs as they may undergo 
transformations from release, through exposure, to uptake and impact in biological systems. 
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4.2. Hazard and Scale 
It is important to state here that while there remains considerable uncertainty in the literature 
regarding the hazards presented by NMs, the authors are clear that a material cannot be declared as 
toxic or non-toxic prior to actual experience (e.g., in a test) just because of its 1 nm to 100 nm scale. 
Science requires that one actually finds out through experimentation on the basis of the actual material 
that one is proposing to manufacture and put into use and finally recycle or dispose of. It is through the 
experimentation that one finds out whether there is a hazard or not and what the mechanism of that 
hazard may be. A lot of high quality experimentation, overcoming the many problems outlined above, 
is required to properly ground the science of nanosafety.  
As an analogy, consider that a boat that is 40 metres long and 10 metres wide is not “automatically” 
more hazardous than a boat that is 4 metres long and 1 metre wide made of the same materials and 
treated under exactly the same conditions. Everything depends on the behaviour of the boat under 
changed or changing conditions, in which the scale may bring with it properties that are relevant where 
they were not relevant before. For example, steering the bigger boat up the River Thames would (no 
doubt) prove to be more hazardous than steering the identical but smaller boat. On the other hand, the 
smaller boat may be more hazardous in a different way, such as under stormy conditions when it may 
have lower stability.  
Scale in the abstract is not relevant, but scale in specific circumstances may (or may not) be 
relevant. Ideally, one has to find out case by case. In practice, ways have to be found of grouping 
cases. In the case of NMs there is growing evidence, not yet sufficiently coherent for technological 
purposes, that a host of characteristics may become relevant under specific conditions, such as  
surface energy, shape, composition, charge, fine surface characteristics, ageing trajectory, molecular 
recognition, tendency to agglomerate, and so on [48]. 
4.3. Biological Interactions 
Nanosafety scientists are especially interested in those conditions that may potentiate the characteristics 
of NMs in biological systems at any level: subcellular, cellular, tissue, organs, organism-systems 
(genetic, immunological, hormonal etc.), organisms, populations of organisms, ecosystems, and 
systems of ecosystems, especially as they impact on human life. This is an enormous field of potential 
study—in fact, potentially it is the entire biosphere [49]. Knowledge-sharing made the authors realize 
that nanosafety scientists must narrow down their research to what is of most concern from the point of 
view of gaining knowledge on hazards perceived to be priorities.  
Most research has been in vitro, with some in vivo, which inevitably raises questions of translation 
and generalization of results. Nanosafety specialists have also understood that real-world studies need 
to pay a lot more attention to long term studies, since certain hazards may only show up over a  
period of years or even decades. Long terms studies would include a concern for the potential for 
bioaccumulation, biodegradation in situ, synergistic effects and perhaps one day even subtle changes in 
cellular signaling 
So far, very few laboratories or small companies have had access to all the different sophisticated 
techniques ideally required to perform full exposure, in situ characterisation and hazard assessment. It 
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is hoped that QNano will help to rectify this situation through the provision of Transnational Access to 
state of the art characterization facilities for nanomaterials and training and dissemination in the need 
for characterization of nanomaterials in the exposure context [46]. One important recognized need is to 
determine the minimum number of metrics necessary to characterise nanoparticles in physiologically 
relevant media (e.g., cell culture media, plasma, lung surfactants, etc.) and how this can be mapped 
onto the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) models. 
Recommendation 23: 
We recommend a well-funded, coordinated and systematic focus on the following NMs: 
(1) a narrow range of ‘common’ NMs (TiO2, ZnO, Ag, Au, Si, C, nanoclays and a few more), that 
is related to; 
(2) a narrow range of specific exposure and release scenarios (occupational inhalation, skin 
absorption, effluent water, waste disposal, abrasion and leaching processes and so on), in; 
(3) a narrow range of specific biological systems (a few whole-organism test species, a few organ 
systems such a lung, heart, nervous system, a few organism-systems such as the immunological, and a 
few limited aspects of an ecosystem such as soil or fresh water, and so on.  
4.4. Ecological Systems, Including Marine and Soil 
Harms to ecological systems often generate over time the conditions for general harms to humans. 
Five years ago, assessment of the environmental hazards of NMs was in its infancy. The knowledge on 
NMs’ impacts on aquatic organisms was more advanced, although very many gaps still existed [50–52]. 
Most work was focussed on a few freshwater species (daphnids, some fish species and single-celled 
pelagic algae) and some microbial systems. Since that time this primary and exploratory research work 
has expanded to cover a wider range of phyla, although with variable incidence, and a wide range  
of endpoints.  
Only five years ago very few papers existed at the time using terrestrial organisms as test species, 
and this gap was also very acute regarding impacts on plants [52].  
Discussions on the importance of characterisation of the relevant properties of NMs for 
environmental studies were also in very early stages. Environmental scientists were learning rapidly 
from human toxicologists drawing on the wealth of knowledge from the respiratory toxicology 
community, especially on ultrafine particles. 
Exposure characterisation in the soil matrix is not a simple matter and special methods will need 
developing [10]. A core problem is that we cannot detect nanoparticles against the massive background 
of other particulates in the soil. The authors were party to the review of methods that had become 
available for nanoparticles characterisation in complex matrices, including soil [13]. Much progress 
had been made, with techniques like Scanning Electron Microscopy with an Energy Dispersive  
X-Ray Analyser (SEM-EDX), x-ray spectroscopy using synchrotron radiation, but also single-particle 
Inductively coupled plasma mass spectrometry (SP-ICP-MS) and flow field-flow fractionation coupled 
to ICP-MS (F-FFF-ICP-MS).  
Recommendation 24: Regarding soil we recommend that research priority is given to the 
following: development of new methods for nano-characterisation in soil and tissues (including 
cheaper methods for use in standard testing schemes); assessment of nanomaterial evolution in soil 
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system; method development for better assessment of actual exposure of soil organisms to NMs; 
assessment of the nanomaterial characteristics driving their potential accumulation in food chains; the 
development of effect-markers to address mode-of-action in soil organisms; coupling of nanomaterial 
properties to their fate in soil, and effects in organisms (short to medium term). 
Knowledge is also required on fluxes or rates instead of distribution coefficients on which models 
for chemicals are often dependent. Important rates include rates of sedimentation, re-suspension, 
bioaccumulation, deposition and run-off fluxes. More information is needed on agglomeration, 
behaviour of agglomerates, sinks i.e., local accumulation, and understanding of what happens at the 
interfaces between water and sediments and water and biological surfaces. 
Recommendation 25: There is some urgency for funded research into future cumulative impacts of 
NMs (especially metallic NMs) on marine phytoplankton, which are vital to life on earth since they 
produce about 50% of oxygen and are a major atmospheric carbon sink [53–55].  
Recommendation 26: For the scientific design of ecotoxicology studies a multi-partner approach is 
essential. Even simple assays can generally not completely be addressed by a single partner.  
4.5. The Life Cycle Approach 
The systematic and formalized investigation of the product life cycle stages (i.e., design, production, 
transport and distribution, use and consumption, misuse, re-use, recycling and disposal) provides a 
holistic perspective on the hazards, risks, benefits and opportunities of nanoproducts. Even less 
formalized and rather qualitative life cycle concepts may uncover prospective knowledge and 
knowledge gaps.  
The term “life cycle assessment (LCA)” stands for a clearly defined methodological framework that 
has been developed in the early 1990’s as reported e.g., in the ISO 14040/14044 standards. LCA 
experts ideally rely on characterization factors for NMs elaborated by physicists, metrologists and 
toxicologists in order to be able to differentiate bulk material from nanoscale material during the  
LCA steps. LCA experts need knowledge on nanomaterial emissions during all product life cycle  
stages [14].  
Life cycle assessment (LCA) and life cycle impact assessment (LCIA) may be used in the 
nanotechnology field to e.g., assess the relative environmental performance (e.g., material and energy 
consumption) of nanoproducts in comparison with their conventional equivalents. The complementary 
use of these different life cycle concepts with the current knowledge on risk assessment may provide a 
sound basis for informed decision-making by industry and regulators. 
Only a few real risk assessment scenarios have been carried out so far for NMs [56]. A robust 
analysis of what would be needed so that this approach could be pursued has to be conducted to 
identify the main obstacles. 
Sources of misunderstandings about LCA, limitations of approaches and potential ways forward 
have been uncovered during the project. No comprehensive Life Cycle Analysis (LCA) can currently 
be pursued due to a lack of information about the production of NMs and their release in different life 
cycle stages [14]. 
Recommendation 27: Life Cycle issues needing targeted funding include methods for trace 
analysis in environmental media; research on ageing NMs; bioaccumulation/biomagnification through 
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the food-chain; and the determination of realistic exposure scenarios for real world applications in 
consumer products through time. In the medium term, an investigation on the “End of life” stage of 
existing products containing real NMs is needed. Funding should attempt to integrate in vitro, ex vivo 
and in vivo toxicology addressing exposure characterization, biokinetics and mechanisms of action, 
and relevant dose justification in relation to exposure assessment.  
Recommendation 28: A coherent approach using laboratory and field measurement strategies 
should be developed and tested for 2–3 selected cases (See Recommendation 23 above). A strategy  
for collection and dissemination of information on the form and amount of NMs incorporated into 
products should be implemented via a mandatory EU reporting system for products containing NMs. 
Recommendation 29: Since some LCA relevant processes can be simulated in the laboratory we 
recommend that standard simulation procedures adapted to specific NMs containing products should 
be tested, validated, established and standardized. In order to apply LCA, and more specifically life 
cycle impact assessment (LCIA), there is a need for a simplified procedure to estimate the potential 
ecotoxic impact of released NMs for comparative purposes, where a lower data requirement would  
be sufficient. 
Recommendation 30: Regulatory bodies should recommend and encourage an industrial and 
innovation approach by which end-of-life information must be fed into start-of life (design) 
information, closing the life cycle. Initial laboratory design of NMs (e.g., polymer NMs) should 
incorporate at this earliest stage of design and development the findings of hazard and risk research  
on nanoparticles, and incorporating knowledge of new materials that have been added to the 
manufacturing process such as nanocatalysts and congeners. This will help avoid toxicity scenarios 
such as those involving PCBs. 
5. General Recommendations for Various Stakeholders 
The development of innovative and enhanced materials generated by nanotechnology is a long-term 
enabling process that will be a major facilitator of an environmentally sustainable and competitive 
economy and will cut across many major industries, including basic materials, electronics, security, 
building and transport, medicine, pharmaceuticals, food and agriculture. Given its novelty and complexity, 
bold and sustained cooperation between industry, regulators, government agencies, regional and 
national funding bodies, academics, research institutions, standardisation organisations and the 
insurance industry is vital. 
For regulatory and scientific purposes, the EC definition of “nanomaterial” will hopefully be the first 
step, in generating a panoply of harmonisation initiatives needed in nanotechnology development [57]. 
Such initiatives would cover CEN/ISO standards, nomenclature, protocols, reference materials, batch 
material uniformity, and technology governance communication, as illustrated in the preceding sections.  
5.1. Industry 
Many industries assess the risks associated with their products, e.g., medical devices, food, 
pharmaceutical, cosmetics and chemical industries. It was reasonable to assume that those industries 
that develop nanotechnology-enabled products are conducting additional safety evaluations, despite the 
fact that current regulations do not oblige them to do so for materials of equivalent chemical 
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composition to ones that are already approved in bulk-scale. However, these data, if in existence, 
generally do not get published in the scientific literature, and thus are not available to the wider 
scientific community. It would be very helpful if information about NMs that industry has found to be 
safe or unsafe by stated criteria were made more widely available to the scientific community.  
Industry and their research teams should provide data about production and use of NMs, together 
with detailed description of used materials, consistent with the legal framework on commercial 
confidentiality, health and safety and the environment. To this end industry needs to be incentivised to 
cooperate more closely with the nanosafety agenda. It should evaluate and define suitable positive and 
negative controls for toxicological research and for evaluating different measurement concepts and 
devices; report as much information as possible about the experiments and the characterisation of 
materials when publishing the data in scientific publications; and contribute to the harmonisation of 
data descriptors for pooling safety and health information in joint databases. It should play a more 
active role in defining research needs, and contribute to networking activities and collaborative 
projects; and support the definition of clear terms of reference for industry participation. 
Industry data are often proprietary information and investments will need to be protected. Firms 
quite legitimately think hard about which partners they might share data with. However, many 
academics and public sector researchers believe it would be a great leap forward if industry scientists 
could be convinced to share their core exposure or dose-response data, for example, in public 
communications or peer-reviewed journals, thus enabling comparative assessments.  
We recommend that industry revise waste management practices to be more relevant to the 
nanoscale nature of particles, such as incinerator temperatures (e.g., for fullerenes), explosivity, etc. 
All mixed nanoparticle-biological waste must be first treated with a sodium hypochlorite solution 
(bleach) or similar to remove biological component. The remaining low volumes of nanoparticles 
should be disposed of as aqueous chemical waste, which goes for incineration.  
Meanwhile, waste management research should obtain data on the leach rate or decay rate of 
nanoproducts (products containing NMs) under realistic landfill conditions (See Recommendation  
3 above). 
5.2. Regulators 
The current REACH guidelines do not have specific inclusions for NMs (see schemes in [58]. A 
pre-requisite to applying a nano-specific sub-set in the REACH strategy will only be logical if a unique 
sub-set of nano-specific biological effects are also identified. So far the latter has been elusive, with 
the toxic mechanisms for NMs (e.g., genotoxicity, respiratory toxicity, inflammation from oxidative 
stress, etc.) also well known for traditional chemicals. There may be uncertainties in some of the 
assumptions behind calculations in REACH for NMs, for example, not knowing if a release is linear 
over time or not in an exposure model. However, these sorts of problems apply to other chemicals too. 
Regulatory bodies need to reconsider the appropriateness of current approaches and consider some 
technical modifications to hazard assessment [59–61]. Action is need on implementing a precise 
decision-tree on how to manage groups of materials through the regulatory process based on shared 
physico-chemical properties and types of probable biological effects.  
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We recommend that regulators pay special attention to exposure and not just adverse effects when 
assessing risks; and in situ characterisation and internal exposure assessment should be part of testing 
strategy for hazard identification. Methods should be developed for a risk management approach to 
protecting workers from potential occupational exposure to carbon nanotubes and nanofibres. 
Currently the research about occupational exposure measurement principles appears to be quite  
well-funded. However, there may be large gaps regarding the assessment of populations of workers 
that could inform epidemiological research about the types of NMs, approximate levels and durations 
of exposure and their link to population characteristics such as job, activity and company profiles.  
We recommend that EU member states implement a mandatory system of reporting of NMs in 
products to include size and size distribution, composition and surface treatment or coating. 
Regulatory agencies are advised to support the setting up of databases and registries—derived from 
cross-disciplinary searchers—that allow storing, pooling and analysing such data for purposes such as 
the assessment of potential health effects or the evaluation of the effectiveness of existing exposure 
reduction measures. 
5.3. Environmental and Health Researchers 
Environmental and health researchers and research bodies, whether in the public or private sector, 
are facing quite a challenge in regard to NMs, not least because some NMs may be persistent and 
cumulative. Currently no environmental monitoring technology is in place to allow for the monitoring 
of the expected increased environmental concentrations of persistent NMs. While we recommend this, 
it is certainly one point of future research which is currently not seen to be an easy task. We suggest 
that for the time being concentrations in the environment have to be predicted rather than measured.  
Environmental studies have so far been limited to release-related studies such as Kaegi et al. [62] 
on the TiO2 wash-off from facades. The main way of assessing possible environmental concentration 
currently is using emission-based approaches and models such as those pursued by Gottschalk  
et al. [63] Here they use information on production rates, release fractions, assumed or based on 
measurement (e.g., sewage plant studies), and environmental transport to model environmental 
concentrations. These concentrations may be compared with environmental no-effect levels for plants, 
animals and humans to assess a possible risk. Still the application of the model is limited to a priori 
information which would be good to overcome in the future. 
We suggest that the traditional approach for determining risk characterization ratios (EUSES)  
does not work, and EUSES predictions of environmental concentrations may not be applicable to 
nanoparticles, since nanoparticles are dispersed rather than dissolved. Suspension (and rate of 
dissolution) is not modelled for conventional chemicals. The tendency of nanoparticles to aggregate 
and agglomerate is also obviously not considered for conventional chemicals. It is unclear how to 
model partitioning of NMs attached to solid surfaces because the following are unknown or not 
included in current models: the extent/rate of dissolution; the extent or rate of agglomeration or 
settling; and the extent of association with sediment. 
Recommendation 31: Distribution models must be updated to encompass NMs, and the focus 
should be on quantifying distributions e.g., for “suspended dissolved”. In addition there is a need to 
focus on obtaining the fundamental understanding of distributions. This knowledge can then be used to 
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develop models. Urgent attention should be given to finding a replacement for the octanol-water 
partition coefficient (Kow). A parameter other than Kow is required for predicting solid phase-water 
partitioning, but more research in NM partitioning in environmental phases is needed before such 
replacements can be made. It is likely that the following parameters will assist in deriving the most 
relevant descriptors for NM distribution in the environment: size distribution, shape, coating/surface 
chemistry, synthesis method, state of agglomeration, shape, “pure” NMs vs. formulation/embedded 
NMs. Furthermore, affinity for adsorption of natural organic matter (NOM) and zeta potential with 
NOM as well as dissolution rate may be of high value.  
Recommendation 32: Routine methods should be developed for the quantification of NMs in 
tissues, both total mass concentration and particle number concentration per g of tissue. There are 
detection limits in environmental samples and there is a technical gap of some three orders of 
magnitude. Current instrumentation only works down to mg/l, but environmental concentrations  
are ng-µg/L. The timescale is short and medium term. This is a technical barrier to developing 
environmental monitoring programs at national levels. There are currently none for NMs in river water 
or soil.  
5.4. Governmental Agencies and Funders 
The authors helped to identify a number of limitations of the OECD Technical Guidance Document 
(TGD) for Risk Assessment of Chemicals in relation to environmental exposure: a lack of information 
on physico-chemical properties relevant for NMs; a lack of access to information on production, 
emissions throughout the life-cycle, etc.; fundamental limitations of the various assumptions  
made such as Kow being a good descriptor for processes like sorption and bioconcentration; and 
fundamental limitations of the various models of fate and degradation of NMs since they are developed 
for organic chemicals and for non-particulates. We propose the development of three interacting 
models: one for dissolved ions, one for NMs and one for aggregates and agglomerates. 
Recommendation 33: Government agencies fund and/or conduct more exposure monitoring at 
workplaces along the process of production, use and elimination and recycling in order to make more 
data available for risk assessors and researchers. They should set up registries of potentially exposed 
workers and if possible add information about exposure measurements and health assessments. 
Recommendation 34: Specific public funding is required for the development of material-specific 
analytical methods, such as routine analytical methods for characterisation of NMs in complex 
matrices; interaction of specific NMs and cellular energy metabolism (with the generation of Reactive 
Oxygen Species as a side product); the establishment of clear Structure-Property Relationships which 
govern the interaction with, uptake by, trafficking within and response of biological systems. 
Recommendation 35: One of the highest priorities must be funding to develop routine methods for 
the measurement of NMs in tissues. For example, information on tissue concentrations would be used 
to link cause and effect (dose-response), used to calculate key parameters in environmental risk 
assessments like bioconcentration factors (see Handy et al., 2012 [64] for concerns regarding these 
tests), or be needed for the pharmacokinetics that are an absolute requirement for the registrations of 
new medicines. These are potential bottlenecks that can prevent a product being registered, and 
therefore prevent innovation.  
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Recommendation 36: The kinetics of NMs in biological systems need funded research. Particle 
systems of well-defined and systematically variable physico-chemical properties should be employed. 
Some problems areas needing urgent study are as follows: The role of NMs and ‘Trojan horse’ uptake 
of contaminants (see Recommendation 1 above); and the relation between the ageing of NMs and the 
kinetics of NMs in biological systems. There is a need for funding of research on discrete body 
systems (cardiac, renal, neural, hormone system, etc.) where they have been given little attention so 
far. Regarding human related hazard assessment only data from animal studies are accepted so far but 
in vitro human models and co culture human models are crucially important to be further developed 
and considered in near future in combination with high throughput technologies and use of quality 
assurance and nano-specific reference standards following good laboratory practice. 
Recommendation 37: Regional and global environmental agencies should consider funding in a 
number of areas where knowledge is negligible, such as organisms that are not standard OECD test 
organisms and searching for new end-points for NM interactions. Nearly all our existing knowledge 
comes from a few organisms used mainly in regulatory tests from freshwater. Risk assessors currently 
cannot construct species sensitivity distributions (no data on different species) and we are a long way 
from the notion of ‘protecting most of the organisms most of the time’ in ecosystems. Gaps include 
amphibians, birds, reptiles, and most of the marine phyla, and non-crop plants. Data on tropical 
ecosystems are also lacking.  
6. Conclusions 
The four-year project NanoImpactNet made significant progress towards the building of consensus 
regarding approaches to nanosafety assessment, and the development of a framework for sharing 
information, best practice, approaches and protocols. In addition, the project experts identified 
significant knowledge-gaps and made a number of important recommendations for researchers, 
industry and funding agencies in order to rapidly progress the field. Especially recommended are that 
all parties involved in NMs production re-evaluate traditional methods and metrics to improve methods 
appropriate to exposure to nanoscale entities, and an ongoing review of all workplace particulate 
protection equipment. Inter alia, the authors recommend better characterisation of NMs at production, 
and approaches that integrate rather than separate exposure and toxicity for realistic modelling. 
Regulatory bodies should encourage an industrial and innovation approach by which mid-life and  
end-of-life information must be fed into start-of life (design) information, closing the life cycle of 
NMs. The authors offer recommendations to industry for safe handling of NMs and propose that EU 
member states implement a mandatory reporting of NMs in products to include size and size 
distribution, composition and surface treatment or coating. 
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